BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16611920)

  • 1. Linkage of reduced receptor affinity and superinfection to pathogenesis of TR1.3 murine leukemia virus.
    Murphy SL; Chung-Landers M; Honczarenko M; Gaulton GN
    J Virol; 2006 May; 80(9):4601-9. PubMed ID: 16611920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of syncytia by neuropathogenic murine leukemia viruses depends on receptor density, host cell determinants, and the intrinsic fusion potential of envelope protein.
    Chung M; Kizhatil K; Albritton LM; Gaulton GN
    J Virol; 1999 Nov; 73(11):9377-85. PubMed ID: 10516046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TR1.3 viral pathogenesis and syncytium formation are linked to Env-Gag cooperation.
    Murphy SL; Gaulton GN
    J Virol; 2007 Oct; 81(19):10777-85. PubMed ID: 17634219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic R-peptide of murine leukemia virus envelope protein negatively regulates its interaction with the cell surface receptor.
    Kubo Y; Izumida M; Togawa K; Zhang F; Hayashi H
    Virology; 2019 Jun; 532():82-87. PubMed ID: 31035110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparate regions of envelope protein regulate syncytium formation versus spongiform encephalopathy in neurological disease induced by murine leukemia virus TR.
    Murphy SL; Honczarenko MJ; Dugger NV; Hoffman PM; Gaulton GN
    J Virol; 2004 Aug; 78(15):8392-9. PubMed ID: 15254211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathogenic murine leukemia virus TR1.3 induces selective syncytia formation of brain capillary endothelium.
    Landers MC; Dugger N; Quadros M; Hoffman PM; Gaulton GN
    Virology; 2004 Mar; 321(1):57-64. PubMed ID: 15033565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo distribution of receptor for ecotropic murine leukemia virus and binding of envelope protein of Friend Murine leukemia virus.
    Yamaguchi S; Hasegawa M; Suzuki T; Ikeda H; Aizawa S; Hirokawa K; Kitagawa M
    Arch Virol; 2003 Jun; 148(6):1175-84. PubMed ID: 12756622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebral hemorrhages and syncytium formation induced by endothelial cell infection with a murine leukemia virus.
    Park BH; Lavi E; Blank KJ; Gaulton GN
    J Virol; 1993 Oct; 67(10):6015-24. PubMed ID: 8396666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
    Tailor CS; Kabat D
    J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
    Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
    Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein.
    Johnston ER; Albritton LM; Radke K
    J Virol; 2002 Nov; 76(21):10861-72. PubMed ID: 12368329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two distinct mechanisms regulate recruitment of murine leukemia virus envelope protein to retroviral assembly sites.
    Lucas TM; Lyddon TD; Grosse SA; Johnson MC
    Virology; 2010 Sep; 405(2):548-55. PubMed ID: 20655565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.
    Lavillette D; Ruggieri A; Boson B; Maurice M; Cosset FL
    J Virol; 2002 Oct; 76(19):9673-85. PubMed ID: 12208946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein.
    Lavillette D; Boson B; Russell SJ; Cosset FL
    J Virol; 2001 Apr; 75(8):3685-95. PubMed ID: 11264358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.
    Song YE; Olinger GY; Janaka SK; Johnson MC
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
    Sandrin V; Muriaux D; Darlix JL; Cosset FL
    J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amphotropic and ecotropic murine leukemia virus envelope TM subunits are equivalent mediators of direct membrane fusion: implications for the role of the ecotropic envelope and receptor in syncytium formation and viral entry.
    Ragheb JA; Yu H; Hofmann T; Anderson WF
    J Virol; 1995 Nov; 69(11):7205-15. PubMed ID: 7474142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of infectious murine leukemia virus production by Fv-4 env gene products exerting dominant negative effect on viral envelope glycoprotein.
    Takeda A; Matano T
    Microbes Infect; 2007; 9(14-15):1590-6. PubMed ID: 18023391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of different but overlapping determinants in a retrovirus receptor accounts for non-reciprocal interference between xenotropic and polytropic murine leukemia viruses.
    Van Hoeven NS; Miller AD
    Retrovirology; 2005 Dec; 2():76. PubMed ID: 16354307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of the naturally occurring soluble surface glycoprotein of ecotropic murine leukemia virus: binding specificity and possible conformational change after binding to receptor.
    Ikeda H; Kato K; Suzuki T; Kitani H; Matsubara Y; Takase-Yoden S; Watanabe R; Kitagawa M; Aizawa S
    J Virol; 2000 Feb; 74(4):1815-26. PubMed ID: 10644355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.